Recent insider trading activity from Kelly Thomas Patrick, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 15, 2025 | Xenon Pharmaceuticals Inc. | $XENE | Kelly Thomas Patrick | Chief Financial Officer | A | Share Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 79,247,976 | 9999.99% | 0.28% |
| Oct. 15, 2025 | Xenon Pharmaceuticals Inc. | $XENE | Kelly Thomas Patrick | Chief Financial Officer | A | Restricted Share Units | 30000 | $0.00 | 30,000.0000 | 79,247,976 | 9999.99% | 0.04% |